HBeAg and Anti-HBe: Markers of Infectivity, Chronicity, and Seroclearance in Hepatitis B
HBeAg Indicates High Infectivity
HBeAg presence correlates directly with viral replication and high infectivity in both acute and chronic HBV infection. 1 The presence of HBeAg indicates high levels of viral replication, with HBV DNA levels typically ranging from 200,000 to 2 billion IU/ml in HBeAg-positive chronic hepatitis B. 2
- Infectivity rates are dramatically higher with HBeAg positivity: Prior to postexposure prophylaxis, approximately 85% of infants born to HBeAg-positive mothers acquired HBV infection, compared to only 30% for HBeAg-negative mothers. 1
- HBeAg can be detected in persons with acute or chronic HBV infection and serves as a marker of active viral replication. 1
- The presence of HBeAg generally demonstrates high viral replication and increased infectivity risk. 3
Anti-HBe Does NOT Indicate Chronicity—It Indicates Reduced Viral Replication
The statement that anti-HBe indicates chronicity is incorrect; anti-HBe actually correlates with loss of replicating virus and reduced infectivity. 1 Anti-HBe emergence typically signals a favorable transition in the disease course.
Anti-HBe in Chronic Infection Context:
- After spontaneous HBeAg seroconversion (development of anti-HBe), 67-80% of carriers enter the "inactive carrier state" with low or undetectable HBV DNA (<2,000 IU/ml) and normal ALT levels. 2
- Anti-HBe positivity usually indicates decreased or undetectable HBV DNA and lower levels of viral replication. 4
- The inactive HBsAg carrier state is characterized by HBeAg negativity, anti-HBe positivity, serum HBV DNA <2,000 IU/ml, and persistently normal ALT/AST levels. 2, 3
Important Caveats:
- Approximately 10-30% of anti-HBe positive patients continue to have elevated ALT and high HBV DNA levels after HBeAg seroconversion, representing HBeAg-negative chronic hepatitis B. 2
- About 4-20% of inactive carriers may revert back to HBeAg positivity. 2
- Roughly 10-20% of inactive carriers may have reactivation of HBV replication after years of quiescence. 2
- HBeAg-negative chronic hepatitis B patients harbor HBV variants in the precore or core promoter region that prevent HBeAg production despite ongoing viral replication. 2
HBsAg Negativity with Anti-HBe in Acute Hepatitis B
In acute hepatitis B, HBsAg negativity combined with anti-HBe presence indicates resolving infection and predicts seroclearance. 1
Serologic Evolution in Acute Hepatitis B:
Two distinct patterns occur during acute hepatitis B: 5
- Pattern A: HBeAg appears only during early acute phase without subsequent anti-HBe detection
- Pattern B: HBeAg is not detected during acute illness, but anti-HBe appears 4-6 weeks after jaundice onset while HBsAg is still present, before anti-HBs appearance
In acute resolving infection, patients may be HBsAg-negative, anti-HBc positive (both IgM and total), with or without anti-HBs, and with or without detectable HBV DNA. 1
Anti-HBc appears 1-2 weeks after HBsAg in acute infection. 1, 6 IgM anti-HBc becomes undetectable within 6 months in most cases of acute infection. 1
Resolved Hepatitis B Criteria:
Resolved hepatitis B is defined by: 2
- Previous known history of acute or chronic hepatitis B or presence of anti-HBc and anti-HBs
- HBsAg negativity
- Undetectable serum HBV DNA
- Normal ALT levels
Clinical Significance:
- The presence of anti-HBs (not anti-HBe alone) typically indicates immunity from HBV infection and appears 3-4 months after HBsAg elimination in persons who recover. 6
- Anti-HBe may help discriminate between various states of hepatitis B virus infection, particularly in anti-HBc-positive but HBsAg- and anti-HBs-negative sera. 7
- The antibody response to HBeAg is of shorter duration than that to HBsAg and HBcAg. 7